SCHEMBL7704425

SCHEMBL7704425

CC(CNc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.52
CHEK1 O14757 13/20 0.49
CDK1 P06493 1/20 0.48
CDK2 P24941 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7704710 0.90 KDR (0.54) KDRCHEK1CDK1CDK2
SCHEMBL7696233 0.90 KDR (0.62) KDRCHEK1CDK1CDK2
SCHEMBL7701433 0.90 KDR (0.53) KDRCHEK1CDK1CDK2
SCHEMBL7091164 0.85 CHEK1 (0.50) KDRCHEK1CDK1CDK2
SCHEMBL7162844 0.82 CHEK1 (0.63) KDRCHEK1CDK1CDK2
SCHEMBL7700607 0.80 CHEK1 (0.45) KDRCHEK1
SCHEMBL7701582 0.76 KDR (0.70) KDRCHEK1CDK1CDK2
SCHEMBL7095976 0.76 CHEK1 (0.55) KDRCHEK1CDK2
SCHEMBL6999873 0.75 KDR (0.50) KDRCHEK1CDK1CDK2
SCHEMBL6996897 0.75 CHEK1 (0.65) KDRCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144415-A2 FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS WARNER-LAMBERT COMPANY (US) 2001-10-17 EP claimed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000042045-A2 FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS WARNER-LAMBERT COMPANY (US) 2000-07-20 WO claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
EP-1144415-A2 FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS WARNER-LAMBERT COMPANY (US) 2001-10-17 EP disclosed
WO-2000042045-A2 FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed